Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02EYZ
|
|||
| Former ID |
DIB007638
|
|||
| Drug Name |
GSK2654909A
|
|||
| Indication | Virus infection [ICD-11: 1A24-1D9Z] | Phase 1 | [1] | |
| Company |
Glaxosmithkline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01659086) Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.